MY IBD PASSPORT. Helping to keep me on track
|
|
- Eunice McKenzie
- 5 years ago
- Views:
Transcription
1 MY IBD PASSPORT Helping to keep me on track
2 This health passport belongs to: Name: Address: Home phone: Other phone: Emergency contact: Phone: Other phone: In this health passport, you will be able to enter important health information related to your inflammatory bowel disease (IBD). It will help you keep track of your tests, medications, vaccinations, surgeries and more. So make sure you bring it to all your appointments, especially when you visit a new health care professional. This health passport is meant as a notebook. Don t hesitate to ask your doctor if you have questions or would like more information.
3 My health care team Gastroenterologist: Clinic/Office address: Phone: Fax: IBD Nurse: Clinic/Office address: Phone: Fax: Secretary: Phone: Fax: Gastrointestinal or inflammatory bowel disease nurse.
4 Family physician: Clinic/Office address: Phone: Fax: Pharmacy: Address: Phone: Fax:
5 My health care team Nutritionist: Clinic/Office address: Phone: Fax: Stomotherapist: Phone: Fax: Other specialist: Clinic/Office address: Phone: Fax:
6 My medical profile My treatment goal
7 My medical profile Disease diagnosis Crohn s disease Date of diagnosis: At diagnosis Ulcerative Colitis Date of diagnosis: Indeterminate Colitis Date of diagnosis: Other (specify): Date of diagnosis: Location of disease Shade in the location of your disease at diagnosis and now. Perianal involvement: Abscess Skin tags Fissure Fistulae
8 Now (Date: )
9 My medical profile Allergies or food intolerance
10 Other significant medical conditions List any other medical conditions you had at diagnosis. Mouth Mouth sores Skin Erythema nodosum Pyoderma gangrenosum Psoriasis Joints Swollen joints Ankylosing spondylitis Liver Primary sclerosing Autoimmune hepatitis cholangitis (PSC) Eyes Iritis Uveitis Cataract Cancer (specify): Other (specify):
11 My medical profile Surgeries Shade in the portions of your digestive tract that were removed and include the dates of your surgeries. Other previous surgical procedures (specify):
12 Physical changes Date: Weight: Height: Date: Weight: Height: Date: Weight: Height: Date: Weight: Height: Date: Weight: Height: Date: Weight: Height: If you would like to know more about monitoring and assessing children s growth, visit for Canadian adaptations of the World Health Organization growth charts. Smoker Yes No If yes, planned stop date:
13 My family history Family history IBD: Colorectal cancer: Other malignancies (specify): Other (specify): Prescription drug insurance Prescription drug coverage plan:
14 My medication Aminosalicylates Generic name Taken in past Sulfasalazine 5-aminosalicylic acid Number of times medication has been taken in the past. Antibiotics Generic name Taken in past Ciprofloxacin Metronidazole Number of times medication has been taken in the past. Currently taking Currently taking Dosage Immunomodulators and immunosuppressants Generic name Taken in past 6-mercaptopurine Azathioprine/Imuran Methotrexate Cyclosporin Number of times medication has been taken in the past. Currently taking Dosage Dosage Side effects/ comments Side effects/ comments Side effects/ comments
15 My medication Corticosteroids Generic name Taken in past Currently taking Prednisone Methylprednisone Budesonide Number of times medication has been taken in the past 12 months. Dosage Side effects/ comments Other medications I am taking or have taken List any medications or supplements (e.g., vitamins, herbal products) you take, or have taken, for reasons other than for your disease. Brand and/or generic name Taken in past Currently taking Side effects/ comments
16 My tests Biologics Tuberculosis (TB) test Date: Result: mm quantiferon Negative Positive Chest X-ray results Date: Verified by: Normal Abnormal Comments: Others (specify) Test: Date: Result:
17 My medication Biologics Generic name Start date Stop date Concomitant immunosuppressant Side effects/ comments Adalimumab Infliximab Golimumab Vedolizumab
18 If you are currently taking a biologic for your disease, and should you develop signs or symptoms of infection (e.g., a fever) or have to take antibiotics, it is important that you speak with your doctor as soon as possible to obtain recommendations. Your biologic therapy may have to be suspended during the episode of infection. If you have any questions, do not hesitate to speak with your health care team.
19 My medical profile Immunization The tables on the next page briefly summarize the Canadian Immunization Guide recommendations for people* with a chronic inflammatory disease before and while undergoing immunosuppressive therapy.
20 Vaccine recommendations BEFORE immunosuppressive therapy Date Recommended inactivated vaccines Recommended live vaccine Pneumococcal Hepatitis B may be considered in seronegative patients Varicella (if varicella susceptible) or herpes zoster may be considered Live vaccines contain weakened forms of the organism that causes the disease and are generally contraindicated during immunosuppressive therapy. Vaccine recommendations WHILE UNDERGOING immunosuppressive therapy Recommended Trivalent inactivated influenza vaccine annually Date If you have any question about vaccination, talk to your doctor or nurse. * For children s vaccination recommendations, please talk to your doctor or nurse. Please see complete details at
21 My medical profile Immunization If you would like to know more about your provincial immunization schedule, don t hesitate to visit the vaccination Web site of your province or territory. British Columbia Alberta Saskatchewan Manitoba Ontario Quebec Newfoundland & Labrador New Brunswick Nova Scotia Prince Edward Island Yukon Nunavut Northwest Territories immunization-services#immunization-programs www2.gnb.ca/content/gnb/en/departments/ocmoh/cdc/content/immunization.html
22 Tests Diagnostic tests List any diagnostic tests (colonoscopy, upper endoscopy, calprotectin, C-reactive protein, CT or X-ray scans, ultrasound, MRI, MRE) relevant to your IBD that you have undergone. Include any important information about these tests.
23 Other important tests Depending on your treatment and/or your condition, routine testing may be recommended. List any routine examination that you have undergone. Date Results Comments Pap test* Skin examination Surveillance colonoscopy * For women
24 Useful Web sites Canadian Web sites Crohn s and Colitis Canada Canadian Digestive Health Foundation Gastrointestinal Society The IBD Foundation Gut Inspired Intestinal Disease Education and Awareness Society (IDEAS) McGill University Health Centre Mount Sinai Hospital Health Canada-Healthy Eating
25 International Web sites Crohn s and Colitis Foundation of America International Foundation for Functional Gastrointestinal Disorders Mayo Clinic MedicineNet.com MedlinePlus You and IBD An Animated Patient s Guide to Inflammatory Bowel Disease (IBD) The Web sites suggested in this brochure do not imply an endorsement of or association with third-party organizations/ Web sites and are provided for information purposes only. AbbVie is not responsible for content of non-abbvie sites.
26 Proud supporters of My IBD Passport Canadian Digestive Health Foundation (CDHF) The mission of the Canadian Digestive Health Foundation is to reduce suffering and improve quality of life by providing trusted, accessible and accurate information about digestive health and disease. The Foundation empowers Canadians to manage their digestive health with confi dence and optimism. Crohn s and Colitis Canada Crohn s and Colitis Canada is committed to educating patients, families, healthcare industry and government about IBD. Become your own health advocate by being better informed about IBD. Visit for up-to-date IBD resources. Canadian Association of Gastroenterology (CAG) The Canadian Association of Gastroenterology has over 1100 members including gastroenterologists, surgeons, pediatricians, basic scientists and nurses. CAG remains dedicated to research, professional education, and patient care in all areas of digestive health and disease, in support of the economic and social health of all Canadians. The information, opinions, recommendations and/or procedures expressed or depicted in this material do not necessarily refl ect those of the CAG.
27 Questions/notes In case of a flare, you should speak to: Name: Number: Use the space below as a memory aid to write down any questions for your health care team, concerns regarding your treatment or disease, and/or changes to your symptoms.
28
29 Appointments Date: Time: Doctor: Date: Time: Doctor: Date: Time: Doctor: Date: Time: Doctor: Date: Time: Doctor: Date: Time: Doctor: Date: Time: Doctor: Date: Time: Doctor: Date: Time: Doctor: Date: Time: Doctor:
30 MY IBD PASSPORT Developed in partnership with Dr. Desmond Leddin MB, FRCP, Professor of Medicine. AbbVie Corporation Printed in Canada HUM/3383A June 2016 abbvie.ca
Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine
Crohn's disease Crohn's disease is an inflammatory condition of the digestive tract that affects children and adults. Common features of Crohn's disease include mouth sores, diarrhea, abdominal pain, weight
More informationInflammatory Bowel Diseases Clinic
UW MEDICINE PATIENT EDUCATION Inflammatory Bowel Diseases Clinic At Harborview Medical Center Welcome Thank you for choosing the Inflammatory Bowel Diseases Clinic at Harborview Medical Center (HMC) for
More informationREPORT CARD BIOLOGIC COVERAGE FOR INFLAMMATORY BOWEL DISEASE IN CANADA, Gastrointestinal Society
REPORT CARD BIOLOGIC COVERAGE FOR INFLAMMATORY BOWEL DISEASE IN CANADA, 2016 Gastrointestinal Society GI (GASTROINTESTINAL) SOCIETY WWW.BADGUT.ORG As the Canadian leader in providing trusted, evidencebased
More informationCrohn s Disease. Resident Lecture 1/17/19
Crohn s Disease Resident Lecture 1/17/19 Objectives Features/Classification of Crohn s Disease Medical Treatment Surgical Indications Surgical Considerations 2 Case 25 yo F presents to your office with
More informationThe ABCs of Inflammatory Bowel Disease. Jennifer Choi, M.D. Associate Director March 31, 2012
The ABCs of Inflammatory Bowel Disease Jennifer Choi, M.D. Associate Director March 31, 2012 What Will This Talk Cover? What is IBD? What causes it? What are complications of it? How do I find out if I
More informationNEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL
NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL CROHN S DISEASE Chronic disease of uncertain etiology Etiology- genetic, environmental, and infectious Transmural
More informationGarrick Brown, MD. Digestive Health Specialists Tacoma Gig Harbor
Garrick Brown, MD Digestive Health Specialists Tacoma Gig Harbor Today s Objectives Define IBD, its potential causes and diagnosis Discuss management and treatment Discuss complementary and alternative
More informationBeyond Anti TNFs: positioning of other biologics for Crohn s disease. Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center
Beyond Anti TNFs: positioning of other biologics for Crohn s disease Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center Objectives: To define high and low risk patient and disease features
More informationInflectra Frequently Asked Questions
Inflectra Frequently Asked Questions 1. What is the funding status of Inflectra (infliximab)? Earlier in 2016, Inflectra (infliximab) was added to the Ontario Drug Benefit (ODB) Formulary as a Limited
More informationMedical therapies and IBD
Medical therapies and IBD Although there is no cure for IBD, there are many treatment options available. There is no standard treatment for IBD that is effective in all situations or for all patients,
More informationThe 2012 SAGE Wait Time Program: Survey of Access to GastroEnterology in Canada Can J Gastroenterol 2013;27:83-9.
The 2012 SAGE Wait Time Program: Survey of Access to GastroEnterology in Canada Can J Gastroenterol 2013;27:83-9. Desmond Leddin MB, David Armstrong MD, Mark Borgaonkar MD, Ronald J Bridges MD, Carlo A
More informationOUNCE OF PREVENTION WORTH A POUND OF CURE
Healthcare maintenance in the patient with Inflammatory Bowel Disease. OUNCE OF PREVENTION WORTH A POUND OF CURE Your gastroenterologist is NOT your primary care physician Your gastroenterologist is NOT
More informationOxyContin in the 90 days prior to it being discontinued.
Appendix 1 (as supplied by the authors): Supplementary data Provincial Drug Insurance program formulary listing status for OxyNeo by province Province Listing of OxyNeo BC Listed for patients covered by
More informationPEDIATRIC INFLAMMATORY BOWEL DISEASE
PEDIATRIC INFLAMMATORY BOWEL DISEASE Alexis Rodriguez, MD Pediatric Gastroenterology Advocate Children s Hospital Disclosers Abbott Nutrition - Speaker Inflammatory Bowel Disease Chronic inflammatory disease
More informationVACCINATIONS AND INFLAMMATORY BOWEL DISEASE
VACCINATIONS AND INFLAMMATORY BOWEL DISEASE Bob Kizer MD Assistant Professor of Medicine Creighton University School of Medicine CONFLICTS OF INTEREST None 1 AN OPPORTUNITY FOR IMPROVEMENT IBD patients
More informationWhat Will This Talk Cover? 101: The Basics of Inflammatory Bowel Disease. Terms & Abbreviations. What Is Normal GI Anatomy?
101: The Basics of Inflammatory Bowel Disease What Will This Talk Cover? What is IBD? What causes it? What are complications of it? How do I find out if I have IBD? How do we treat IBD? Jennifer Choi,
More informationULCERATIVE COLITIS. Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC
ULCERATIVE COLITIS Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC What is Ulcerative Colitis? Ulcerative colitis (UC) is a disease marked by inflammation
More informationPrior Authorization Conditions for Approval of Humira (adalimumab) Website Form Submit request via: Fax
Prior Authorization Conditions for Approval of Humira (adalimumab) Website Form www.highmarkhealthoptions.com Submit request via: Fax - 1-855-476-4158 All requests for Humira (adalimumab) require a prior
More informationI B D. etter than this. isease UNDERSTANDING INFLAMMATORY BOWEL DISEASES
I B D m etter than this isease UNDERSTANDING INFLAMMATORY BOWEL DISEASES What types of people have learned how to manage their IBD? Athletes Musicians Firefighters DOCTORS HEROES Artists Presidents Actors
More informationWest Nile virus and Other Mosquito borne Diseases National Surveillance Report English Edition
and Other Mosquito borne Diseases National Surveillance Report English Edition July to July 8, 17 (Week 7) West Nile Virus Canada Humans As of surveillance week 7, ending on July 8, 17, the Public Health
More informationINFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic
INFLAMMATORY BOWEL DISEASE Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic WHAT IS INFLAMMATORY BOWEL DISEASE (IBD)? Chronic inflammation of the intestinal tract Two related
More informationTreatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG
Treatment of Inflammatory Bowel Disease Michael Weiss MD, FACG What is IBD? IBD is an immune-mediated chronic intestinal disorder, characterized by chronic or relapsing inflammation within the GI tract.
More information2. Has the patient had a response to treatment? Y N. 3. Does the patient have a diagnosis of rheumatoid arthritis (RA)? Y N
12/21/2016 Prior Authorization Aetna Better Health of West Virginia Humira (WV88) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and
More informationNovember 5 to 11, 2017 (Week 45)
Hanks you Overall Summary November 5 to 11, 2017 (Week 45) Influenza activity crossed the seasonal threshold in week 45, indicating the beginning of the influenza season at the national level. The number
More informationCircle Yes or No Y N. [If no, skip to question 7.] 2. Does the patient have a diagnosis of ulcerative colitis? Y N. [If no, skip to question 4.
06/01/2016 Prior Authorization AETA BETTER HEALTH OF MICHIGA (MEDICAID) Humira (MI88) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign
More informationInflammatory Bowel Disease Medical Exam Questionnaire
Patient Name: MR: Date: Name DOB / / Age Marital Status Race Gender M / F Height Present Weight Usual Weight Insurance Managed Care Self referral Yes No Yes No Yes No Primary Care Physician Referring Physician
More informationTo help you with terms and abbreviations used in this document that may be unfamiliar to you, a glossary is provided on the last pages.
ARTHRITIS CONSUMER EXPERTS 910B RICHARDS STREET VANCOUVER BC V6B 3C1 CANADA T: 604.974-1366 F: 604.974-1377 WWW.ARTHRITISCONSUMEREXPERTS.ORG Arthritis Consumer Experts In Health Care and Research Decision-making
More informationHealth Canada Endorsed Important Safety Information on Infanrix Hexa
Health Canada Endorsed Important Safety Information on Infanrix Hexa October 30, 2012 Dear Health Care Professional: Subject: Voluntary recall of GlaxoSmithKline (GSK) Infanrix Hexa Vaccine Lot A21CB242A
More informationMedical Therapy for Pediatric IBD: Efficacy and Safety
Medical Therapy for Pediatric IBD: Efficacy and Safety Betsy Maxwell, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Pediatric IBD: Defining Remission
More informationCHAPTER 4: Population-level interventions
CHAPTER 4: Population-level interventions Population-level interventions refer to policies and programs that are applied to entire populations to promote better health outcomes. In this chapter, we describe
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 3 October 2012
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 3 October 2012 REMICADE 100 mg, powder for concentrate for solution for infusion B/1 vial (CIP code: 562 070-1) Applicant:
More informationPharmacy Prior Authorization
Pharmacy Prior Authorization MERC CARE PLA (MEDICAID) Humira (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and date. Fax
More informationRecently, the Institute of Musculoskeletal Health and
S P E C I A L F E A T U R E Are the Results of Dental Research Accessible to Canadian Dentists? Christophe Bedos, DCD, PhD Paul Allison, BDS, FDSRCS, PhD A b s t r a c t The aim of this joint CDA IMHA
More informationDecember 3 to 9, 2017 (Week 49)
Hanks you December 3 to 9, 2017 (Week 49) Overall Summary Overall, Influenza activity continues to increase across Canada; however many indicators such as hospitalizations, outbreaks and geographic spread
More informationVACCINE COVERAGE IN CANADIAN CHILDREN
VACCINE COVERAGE IN CANADIAN CHILDREN RESULTS FROM THE 2013 CHILDHOOD NATIONAL IMMUNIZATION COVERAGE SURVEY (CNICS) REVISED EDITION FEBRUARY 2017 PROTECTING AND EMPOWERING CANADIANS TO IMPROVE THEIR HEALTH
More informationIndex. Surg Clin N Am 87 (2007) Note: Page numbers of article titles are in boldface type.
Surg Clin N Am 87 (2007) 787 796 Index Note: Page numbers of article titles are in boldface type. A Abscesses in anorectal Crohn s disease, 622 intra-abdominal, in Crohn s disease, 590 591 perirectal,
More informationPharmacy Prior Authorization
Pharmacy Prior Authorization AETA BETTER HEALTH PESLVAIA & AETA BETTER HEALTH KIDS Humira (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information,
More informationIBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition
IBD 101 Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Objectives Identify factors involved in the development of inflammatory bowel
More informationMethadone 8.3. Dispensing (Ontario) This document describes the recommended way to setup and dispense Methadone mixtures.
Methadone 8.3 Dispensing (Ontario) This document describes the recommended way to setup and dispense Methadone mixtures. Last Updated: February 15, 2010 Table of Contents Methadone Drug and Mixture Card
More informationLaurie S. Conklin, M.D. Inflammatory Bowel Disease Program Children s National Medical Center
Laurie S. Conklin, M.D. Inflammatory Bowel Disease Program Children s National Medical Center CROHN S DISEASE Patchy inflammation Mouth to anus involvement Full-thickness inflammation Variable involvement
More informationCurrent management options and recent advances in IBD
n DRUG REVIEW Current management options and recent advances in IBD Ben Warner BSc, MRCP and Peter Irving MA, MD, FRCP SPL The advent of biological therapies has revolutionised the management of inflammatory
More informationINFLIXIMAB Remicade (infliximab), Inflectra (infliximab-dyyb), Ixifi* (infliximabqbtx), Renflexis (infliximab-abda)
Pre - PA Allowance None Prior-Approval Requirements Diagnoses Patient must have ONE of the following: 6 years of age or older 1. Moderate to severe Crohn s disease (CD) a. Patient has fistulizing disease
More informationWhat is Crohn's disease?
What is Crohn's disease? Crohn's disease is a chronic inflammatory disorder that causes inflammation of the digestive tract. It can affect any area of the GI tract, from the mouth to the anus, but it most
More information1. Background: Infliximab is administered parenterally; therefore, it is not covered under retail pharmacy benefits.
Subject: Infliximab (Remicade ) Original Original Committee Approval: October 13, 2006 Revised Last Committee Approval: December 3, 2008 Last Review: October 19, 2007 1. Background: Infliximab is a genetically
More informationIBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition
IBD 101 Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Objectives Identify factors involved in the development of inflammatory bowel
More informationDecision relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin)
9 September 2015 Decision relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin) The PHARMAC Board has approved the proposal relating to the funding of the TNF-inhibitor
More informationSpeaker Introduction
Speaker Introduction Stephen B. Hanauer, MD Professor of Medicine and Clinical Pharmacology University of Chicago Pritzker School of Medicine Chief of Gastroenterology, Hepatology, and Nutrition University
More informationSmoking Cessation and the Workplace
Smoking Cessation and the Workplace Profile of Tobacco Smokers and Workplace Smoking Cessation Policies and Programs Louise Chénier Manager, Workplace Health and Wellness Research The Conference Board
More information3. Has the patient shown improvement in signs and symptoms of the disease? Y N
Pharmacy Prior Authorization MERC CARE (MEDICAID) Renflexis (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and date. Fax
More informationEstimating the volume of Contraband Sales of Tobacco in Canada
The Canadian Tobacco Market Place Estimating the volume of Contraband Sales of Tobacco in Canada Updated April 2010 Physicians for a Smoke-Free Canada 1226 A Wellington Street Ottawa, Ontario, K1Y 3A1
More informationWe are here to help Provincial offices The Alzheimer Society works Alzheimer Society B.C. right across Canada
Programs & services Who we are Active in communities across Canada, the Alzheimer Society provides information, support and education to people living with Alzheimer s disease and other dementias. We are
More informationMy Child Has Inflammatory Bowel Disease : Why? What now? What s next?
My Child Has Inflammatory Bowel Disease : Why? What now? What s next? George M. Zacur, M.D., M.S. Clinical Assistant Professor Department of Pediatrics and Communicable Diseases Division of Gastroenterology
More informationCanadian Association of Gastroenterology Clinical Practice Guidelines: The use of infliximab in Crohn s disease
CLINICAL PRACTICE GUIDELINES Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of infliximab in Crohn s disease PARTICIPANTS* Dr Remo Panaccione (Co-chair) University of Calgary
More informationC. Assess clinical response after the first three months of treatment.
Government Health Plan (GHP) of Puerto Rico Authorization Criteria Tumor Necrosis Factor Alpha (TNFα) Adalimumab (Humira ) Managed by MCO Section I. Prior Authorization Criteria A. Physician must submit
More informationPreventive Care and Monitoring of the IBD Patient
Preventive Care and Monitoring of the IBD Patient Francis A. Farraye, MD, MSc, FACG Clinical Director, Section of Gastroenterology Director, Inflammatory Bowel Disease Center Boston Medical Center Professor
More informationHealth Interventions in Ambulatory Cancer Care Centres DRAFT. Objectives. Methods
ENVIRONMENTAL SCAN Health Interventions in Ambulatory Cancer Care Centres Context Cancer, a complex, chronic condition, will affect an estimated two in five Canadians in their lifetime. 1 Cancer requires
More informationvaccination in Canada Bernard Duval, md, mph, frcpc Institut National de Santé Publique du Québec Québec, Canada Sevilla,
Follow-up of hepatitis B vaccination in Canada Bernard Duval, md, mph, frcpc Institut National de Santé Publique du Québec Québec, Canada Sevilla, 2004-03 03-11 HB in Canada Low endemicity: HBsAg+ : 0.5%
More informationINFLAMMATORY BOWEL DISEASE (IBD): CROHN S DISEASE
INFLAMMATORY BOWEL DISEASE (IBD): CROHN S DISEASE Symptoms The symptoms of Crohn s disease can vary from person to person, based on where the disease is in the body and how bad the inflammation is. The
More informationEfficacy and Safety of Treatment for Pediatric IBD
Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Associate Professor of Clinical Pediatrics Division of Gastroenterology,
More informationMethotrexate for inflammatory bowel disease: what you need to know
Methotrexate for inflammatory bowel disease: what you need to know This leaflet aims to answer your questions about taking methotrexate for inflammatory bowel disease (IBD). If you have any questions or
More informationEfficacy and Safety of Treatment for Pediatric IBD
Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Assistant Professor of Clinical Pediatrics Division of Gastroenterology,
More informationCADTH Optimal Use Report
Canadian Agency for Drugs and Technologies in Health Agence canadienne des médicaments et des technologies de la santé CADTH Optimal Use Report Pilot Project Guidance on 1.5 Tesla Magnetic Resonance Imaging
More information2. Does the patient have a diagnosis of ulcerative colitis or Crohn s? Y N
Pharmacy Prior Authorization AETA BETTER HEALTH LOUISIAA (MEDICAID) Remicade (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign
More informationPhysiotherapists in Canada, 2011 National and Jurisdictional Highlights
pic pic pic Physiotherapists in Canada, 2011 National and Jurisdictional Highlights Spending and Health Workforce Our Vision Better data. Better decisions. Healthier Canadians. Our Mandate To lead the
More informationThis information explains the advice about Crohn's disease that is set out in NICE guideline CG152.
Information for the public Published: 1 October 2012 nice.org.uk About this information NICE guidelines provide advice on the care and support that should be offered to people who use health and care services.
More informationCORD Rare Disease Patient Survey
CORD Rare Disease Patient Survey 7 March 2015 Powered by 491 Eng + 61 Fr = 552 Total Responses March 3, 2015 Q1: Who is answering this questionnaire? 534 Responses 3 Q3: What is gender of person with rare
More informationSlide 1 Medications in inflammatory bowel disease a primer for health care providers. Slide 2. Slide 3 Theory of pathogenesis. IBD - epidemiology
Slide 1 Medications in inflammatory bowel disease a primer for health care providers Athos Bousvaros, MD Associate director Inflammatory Bowel Disease Center Boston Children s Hospital 617 355 2962 Slide
More informationWelcome to Week 2 of the Crohn s & Colitis Foundation of America (CCFA) Online Support Group.
Welcome to Week 2 of the Crohn s & Colitis Foundation of America (CCFA) Online. Last week s material consisted of an overview of inflammatory bowel diseases (IBD), specifically Crohn s disease and ulcerative
More informationDO NOT FAX THIS PAGE
Paed-Intestinal Disease Collaboration Projects: Local Registration Record 1. Participant Registration for the Paed-Intestinal Disease Collaboration Projects Participant Study Registration Number: Participant
More informationAppendix A: Introduction to Imaging Modalities for Which Data Were Collected in the 2017 Imaging Inventory
Appendix A: Introduction to Imaging Modalities for Which Data Were Collected in the 207 Imaging Inventory Computed Tomography Computed tomography (CT) employs X-rays as a source of ionizing radiation,
More informationColorectal Cancer Screening in Canada MONITORING & EVALUATION OF QUALITY INDICATORS RESULTS REPORT
Colorectal Cancer Screening in Canada MONITORING & EVALUATION OF QUALITY INDICATORS RESULTS REPORT JANUARY 2011 DECEMBER 2012 Acknowledgments The Canadian Partnership Against Cancer would like to gratefully
More informationPractical Risk Management Tools for Patients with IBD. Garth Swanson MD Rush University Medical Center
Practical Risk Management Tools for Patients with IBD Garth Swanson MD Rush University Medical Center IBD Therapy Severity Tysabri Surgery Infliximab, i Adalimumab, Certilizumab Corticosteroids, Immunomodulators
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES HUMIRA PEDIATRIC
Generic Brand HICL GCN Exception/Other ADALIMUMAB HUMIRA 24800 HUMIRA PEDIATRIC GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW) 1. Is the patient currently taking Humira? If
More informationThe London Gastroenterology Partnership CROHN S DISEASE
CROHN S DISEASE What is Crohn s disease? Crohn s disease is a condition, in which inflammation develops in parts of the gut leading to symptoms such as diarrhoea, abdominal pain and tiredness. The inflammation
More informationProvincial Projections of Arthritis or Rheumatism, Special Report to the Canadian Rheumatology Association
ARTHRITIS COMMUNITY RESEARCH & EVALUATION UNIT (ACREU) The Arthritis and Immune Disorder Research Centre Health Care Research Division University Health Network February, 2000 Provincial Projections of
More informationCROHN S DISEASE. The term "inflammatory bowel disease" includes Crohn's disease and the other related condition called ulcerative colitis.
CROHN S DISEASE What does it consist of? Crohn s disease is an inflammatory process that affects mostly to the intestinal tract, although it can affect any other part of the digestive apparatus from the
More informationP a g e 1. Inflammatory Bowel Disease Guidelines
P a g e 1 Inflammatory Bowel Disease Guidelines Introduction Inflammatory bowel disease (IBD) is a chronic inflammatory disease affecting the gastrointestinal (GI) system. It is comprised of two major
More informationStaying Healthy as an IBD patient
Staying Healthy as an IBD patient Crohn s & Colitis Seattle Education Conference March 28, 2015 Karlee Ausk, MD Swedish Gastroenterology Epidemiology Affects >1.4 million Americans Economic burden $2.8
More informationYour Medical Details and Treatment Tracker. About You
This document is intended to help you keep a record of important details that you may need to share with healthcare professionals throughout your Living with Neuroendocrine Tumours (NETs) journey. Take
More informationTreating inflammatory bowel disease
Treating inflammatory bowel disease Anti TNFa (Infliximab, Adalimumab and Golimumab) Information for patients Gastroenterology This leaflet should not replace the information provided by the drug manufacturer.
More information2. Is the patient responding to Remicade therapy? Y N
09/29/2015 Prior Authorization AETA BETTER HEALTH OF MICHIGA (MEDICAID) Remicade (MI88) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign
More informationHow to manage your IBD patient: Tips for diagnosis and care
How to manage your patient: Tips for diagnosis and care Oriana M. Damas, M.D. Assistant Prof Clinical Medicine Division of Gastroenterology No relevant disclosures Case Presentation: A.R. 32 yo woman with
More informationSpecial Authorization Drug Products with
Effective August 1, 2008 Summary Special Authorization Drug Products with Changes to Criteria Special Authorization Drug Products with Changes to Criteria Alberta Blue Cross has been advised by Alberta
More informationYOUR SEASONAL FLU GUIDE
YOUR SEASONAL FLU GUIDE b What is the seasonal flu? b What can you do to prevent the seasonal flu? b Resources WWW.FIGHTFLU.CA To promote and protect the health of Canadians through leadership, partnership,
More informationThe Road to Remission
The Road to Remission Understanding, Treating and Living with Inflammatory Bowel Disease IBDCenterOrlando.com As many as 1.5 million Americans currently suffer from inflammatory bowel disease (IBD), and
More informationDr David Epstein Vincent Pallotti Hospital and University of Cape Town
Inflammatory Bowel Disease Management in South Africa in 2016 Pharmaceutical Care Management Association Dr David Epstein Vincent Pallotti Hospital and University of Cape Town Inflammatory Bowel Disease
More informationAdalimumab for Inflammatory Bowel Disease. An information guide
TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION Adalimumab for Inflammatory Bowel Disease An information guide Adalimumab for Inflammatory Bowel Disease (IBD) What is Adalimumab and how
More informationABOUT FMC MEMBERSHIP:
ABOUT FMC MEMBERSHIP: FMC and your provincial/territorial association are a part of a network of interdisciplinary professionals made up of private and court connected mediators, lawyers, social workers,
More informationHealth Maintenance & Self Advocacy. Lindsay Masters, BSN, RN Northwest Gastroenterology Associates
Health Maintenance & Self Advocacy Lindsay Masters, BSN, RN Northwest Gastroenterology Associates Health Maintenance Vitamin D/Calcium Vaccines Antibiotics Routine IBD Maintenance Colonoscopies Other care
More informationWhat is ulcerative colitis?
What is ulcerative colitis? Ulcerative colitis is a disease that causes inflammation and sores, called ulcers, in the lining of the rectum and colon. Ulcers form where inflammation has killed the cells
More informationRequest for Special Authorization Enbrel
Certain prescription drugs call for a more detailed assessment to help ensure that they represent reasonable treatment. Special Authorization requires that you request approval from Great-West Life for
More informationRegulatory Status FDA-approved indications: Entyvio is an α4β7integrin receptor antagonist indicated for: (1)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.12 Subject: Entyvio Page: 1 of 7 Last Review Date: September 20, 2018 Entyvio Description Entyvio
More informationInfliximab for Inflammatory Bowel Disease. An information guide
TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION Infliximab for Inflammatory Bowel Disease An information guide Infliximab for Inflammatory Bowel Disease Infliximab is a type of drug known
More informationWHAT IS ULCERATIVE COLITIS?
235 60th Street, West New York, NJ 07093 T: (201) 854-4646 F: (201) 854-4647 810 Main Street, Hackensack, NJ 07601 T: (201) 488-0095 Ulcerative Colitis WHAT IS ULCERATIVE COLITIS? Ulcerative colitis is
More informationMedical Aid in Dying A Year of Change
Medical Aid in Dying A Year of Change Howard Lim, MD, PhD, FRCPC Chair, Gastrointestinal Tumour Group Program Director, Medical Oncology Residency Training Program Clinical Associate Professor, University
More informationTreating Crohn s and Colitis in the ASC
Treating Crohn s and Colitis in the ASC Kimberly M Persley, MD Texas Digestive Disease consultants TASC Meeting Outline IBD 101 Diagnosis Treatment Burden of Disease Role of ASC Inflammatory Bowel Disease
More information3. Did the patient show evidence of remission by week 8 of Humira Y N therapy?
09/23/2015 Prior Authorization AETA BETTER HEALTH OF MICHIGA (MEDICAID) Humira (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information,
More informationUnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1041-8 Program Prior Authorization/Notification Medication Humira (adalimumab) P&T Approval Date 1/2007, 6/2008, 4/2009, 6/2009,
More informationWest Nile Virus and Other Mosquito-borne Diseases National Surveillance Report English Edition September 11 to September 17, 2016 (Week 37)
West Nile Virus and Other Mosquito-borne Diseases National Surveillance Report English Edition September 11 to September 17, 16 (Week 37) Canada Humans During surveillance week 37, ending on September
More information